Official Journal of Research Center for Gastroenterology and Liver Diseases
CrossRef
Works that cite this article, indexed by Crossref.
The Decade-Long Chinese Methadone Maintenance Therapy Yields Large Population and Economic Benefits for Drug Users in Reducing Harm, HIV and HCV Disease Burden
Frontiers in Public Health 7 (2019)
Lei Zhang; Xia Zou; Yong Xu; Nick Medland; Liwei Deng; Yin Liu; Shu Su; Li Ling
Impact of Pharmacological Treatments for Opioid Use Disorder on Mortality
CNS Drugs 34(6) (2020)
Erin Kelty; Gary Hulse; David Joyce; David B. Preen
Portraying Persons Who Inject Drugs Recently Infected with Hepatitis C Accessing Antiviral Treatment: A Cluster Analysis
Hepatitis Research and Treatment 2014 (2014)
Jean-Marie Bamvita; Elise Roy; Geng Zang; Didier Jutras-Aswad; Andreea Adelina Artenie; Annie Levesque; Julie Bruneau
Using hepatitis C prevalence to estimate HIV epidemic potential among people who inject drugs in the Middle East and North Africa
AIDS 29(13) (2015)
Ghina R. Mumtaz; Helen A. Weiss; Peter Vickerman; Natasha Larke; Laith J. Abu-Raddad
Hepatitis C virus infection in Iran: A review of current prevalence and preventive strategies from a developing country
Journal of Clinical Virology Plus 4(3) (2024)
Marcarious M. Tantuoyir; Muhammed Camara; Marjan Sohrabi; SeyedAhmad SeyedAlinaghi; Zahra Ahmadinejad
DOES IT WORK? -a randomized controlled trial to test the efficacy of HCV and HIV-related education on drug users in MMT, China
BMC Infectious Diseases 19(1) (2019)
Jing Ying Zhang; Zhi Bin Li; Lei Zhang; Jun Wang; Le Ping Huang; Gui Lai Zhan; Zhu Li; Jiang Du; Min Zhao
Medical complications of opioid use disorder in pregnancy
Seminars in Perinatology 43(3) (2019)
Mona Prasad; Megan Jones
Methadone Matters: What the United States Can Learn from the Global Effort to Treat Opioid Addiction
Journal of General Internal Medicine 34(6) (2019)
S. L. Calcaterra; P. Bach; A. Chadi; N. Chadi; S. D. Kimmel; K. L. Morford; P. Roy; J. H. Samet
Prevalence of HIV and HCV among injecting drug users in three selected WHO-EMRO countries: a meta-analysis
Harm Reduction Journal 18(1) (2021)
Shah Jahan Shayan; Rajab Nazari; Frank Kiwanuka
Factors associated with HCV risk practices in methadone-maintained patients: the importance of considering the couple in prevention interventions
Substance Abuse Treatment, Prevention, and Policy 9(1) (2014)
Perrine Roux; Caroline Lions; Laurent Michel; Marion Mora; Jean-Pierre Daulouède; Fabienne Marcellin; Bruno Spire; Alain Morel; Patrizia M Carrieri
Medication for opioid use disorder in the Arab World: A systematic review
International Journal of Drug Policy 102 (2022)
Jude Alawa; Muzzammil Muhammad; Maryam Kazemitabar; Daniel J Bromberg; Danilo Garcia; Kaveh Khoshnood; Lilian Ghandour
Gender Differences Among Patients With Hepatitis C Virus Undergoing Rehabilitation Through Methadone Maintenance Treatment
Iranian Rehabilitation Journal 16(1) (2018)
Omid Massah; Enayatollah Bakhshi; Sara Shishehgar; Afsaneh Moradi
The Long-Term Effectiveness of Methadone Maintenance Treatment in Prevention of Hepatitis C Virus: A Modeling Study
Iranian Red Crescent Medical Journal 16(2) (2014)
Mehdi Javanbakht; Alireza Mirahmadizadeh; Atefeh Mashayekhi
The Global State of Harm Reduction in Prisons
Journal of Correctional Health Care 25(2) (2019)
Gen Sander; Sam Shirley-Beavan; Katie Stone
Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in Iran: an updated systematic review and cumulative meta-analysis
Harm Reduction Journal 18(1) (2021)
Abdolhalim Rajabi; Heidar Sharafi; Seyed Moayed Alavian
Male patients’ preferences for opioid use treatment programs
BMC Psychiatry 23(1) (2023)
Mostafa Amini-Rarani; Maryam Moeeni; Koen Ponnet
A Discrete-Choice Experiment to Assess Patient Preferences for Long-Acting Injectable Treatments in Opioid Use Disorder in Australia, Finland, Germany, and Italy
International Journal of Mental Health and Addiction 24(5) (2026)
Madhusudan Kabra; Shehzad Ali; Mona Sadeghian; Maithreyi Thamattoor; Tim MacDonald; Nils Lenuweit; Ulriika Sundell; Michela Moscone; Heidi Holmström Larm; Radha Sharma
Molecular diagnosis of occult hepatitis C virus infection in Iranian injection drug users
Archives of Virology 164(2) (2019)
Maryam Sheikh; Farah Bokharaei-Salim; Seyed Hamidreza Monavari; Angila Ataei-Pirkooh; Maryam Esghaei; Najmeh Moradi; Roghayeh Babaei; Atousa Fakhim; Hossein Keyvani
Treatment of Chronic Hepatitis C in Patients Receiving Opioid Agonist Therapy
Infectious Disease Clinics of North America 32(2) (2018)
Brianna L. Norton; Matthew J. Akiyama; Philippe J. Zamor; Alain H. Litwin
Correlation between interleukin-6 levels and methadone maintenance therapy outcomes
Drug and Alcohol Dependence 204 (2019)
Ru-Band Lu; Tzu-Yun Wang; Sheng-Yu Lee; Shiou-Lan Chen; Yun-Hsuan Chang; Po See Chen; Shih-Hsien Lin; Chun-Hsien Chu; San-Yuan Huang; Nian-Sheng Tzeng; I Hui Lee; Kao Chin Chen; Yen Kuang Yang; Ping Chen; Shih-Heng Chen; Jau-Shyong Hong
The Impact of Completing X-Waiver Training and Clinical Addiction Exposure on Internal Medicine Residents Treating Patients With Opioid Use Disorder
Substance Use & Addiction Journal 45(3) (2024)
Catherine Callister; Samuel Porter; Phillip Vatterott; Angela Keniston; Lauren McBeth; Sarah Mann; Susan L. Calcaterra; Julia Limes
Medicaid And Methadone For Opioid Use Disorder: Expanded Coverage Increased Distribution In 10 States, 2019–24
Health Affairs 44(9) (2025)
Ellen Latsko; Alina Denham; Michael L. Barnett
Depression and its associated factors among people who use drugs attending the Methadone Treatment Clinic at Tumbi Hospital in Pwani, Tanzania: A cross-sectional study
PLOS Mental Health 2(10) (2025)
Anna Chrispo Charle; Masunga K. Iseselo; Sofia Sanga; Kristen A. Morin
HIV among People Who Inject Drugs in the Middle East and North Africa: Systematic Review and Data Synthesis
PLoS Medicine 11(6) (2014)
Ghina R. Mumtaz; Helen A. Weiss; Sara L. Thomas; Suzanne Riome; Hamidreza Setayesh; Gabriele Riedner; Iris Semini; Oussama Tawil; Francisca Ayodeji Akala; David Wilson; Laith J. Abu-Raddad; David D. Celentano
Increasing access to opioid maintenance treatment: The role of primary care in France
International Journal of Drug Policy 26(4) (2015)
P. Roux; C. Lions; M.P. Carrieri
Advancing Service Integration in Opioid Treatment Progams for the Care and Treatment of Hepatitis C Infection
International Journal of Clinical Medicine 05(03) (2014)
Thomas F. Kresina; Robert Lubran; H. Westley Clark; Elinore F. McCance-Katz
The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users
Addiction 109(12) (2014)
Seonaid Nolan; Viviane Dias Lima; Nadia Fairbairn; Thomas Kerr; Julio Montaner; Jason Grebely; Evan Wood
Optimizing Hepatitis C Virus (HCV) Treatment in a US Colocated HCV/Opioid Agonist Therapy Program
Open Forum Infectious Diseases 7(10) (2020)
Jackie Habchi; Aurielle M Thomas; Sophie Sprecht-Walsh; Elenita Arias; Jeffrey Bratberg; Linda Hurley; Susan Hart; Lynn E Taylor
Opioid use, treatment and harm reduction services: the first report from the Persian Gulf region
Journal of Substance Use (2014)
Zahra Alam-mehrjerdi; Roya Noori; Kate Dolan
Methadone initiation in a bridge clinic for opioid withdrawal and opioid treatment program linkage: a case report applying the 72-hour rule
Addiction Science & Clinical Practice 16(1) (2021)
Jordana Laks; Jessica Kehoe; Natalija M. Farrell; Miriam Komaromy; Jonathan Kolodziej; Alexander Y. Walley; Jessica L. Taylor
Factors associated with willingness to participate in a pharmacologic addiction treatment clinical trial among people who use drugs
The American Journal on Addictions 24(4) (2015)
Sasha Uhlmann; Michael John Milloy; Keith Ahamad; Paul Nguyen; Thomas Kerr; Evan Wood; Lindsey Richardson
Barriers to progressing through a methadone maintenance treatment programme: perspectives of the clients in the Mid-West of Ireland’s drug and alcohol services
BMC Health Services Research 18(1) (2018)
Lisa Moran; Eamon Keenan; Khalifa Elmusharaf